We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » Pharmaceuticals » Regulatory Affairs

Regulatory Affairs
%{topic} RSS Feed RSS

Coronavirus Vaccine Makers Testify Before House Subcommittee, Promise Supply Boost

February 24, 2021
COVID-19 vaccine makers appearing yesterday before a U.S. House subcommittee pledged to lawmakers they would meet — and in some cases accelerate — their vaccine supply commitments, as the federal government and states clamor for more doses one year into the pandemic. Read More

FDA’s Office of Clinical Pharmacology Touts COVID-19 ‘Strike Teams’

February 23, 2021
The FDA’s Office of Clinical Pharmacology’s strike teams were directly involved in the agency’s efforts to battle the COVID-19 pandemic in 2020, according to an annual report it published Monday. Read More

FDA Outlines Data Required for Modifying COVID-19 Vaccines Against Viral Variants

February 23, 2021
The FDA has published draft guidance letting COVID-19 vaccine developers that modify authorized vaccines against new viral variants know what they need to present to the agency for amending Emergency Use Authorizations (EUAs), noting that it doesn’t expect large-scale trials will be needed for the altered versions. Read More

European Commission Forges New Vaccine Supply Pacts With Pfizer, Moderna

February 22, 2021
The EC has secured an additional 300 million doses from Moderna and has inked a deal with Pfizer for a further 300 million doses of its vaccine co-developed with BioNTech. Read More

Charles River Strengthens Grasp of Cell and Gene Therapy With Cognate Purchase

February 22, 2021
In the latest in a series of recent moves that greatly expand its presence in cell and gene therapies, Charles River Laboratories is acquiring Cognate BioServices, a Baltimore, Md.-based cell and gene therapy contract development and manufacturing firm for $875 million. Read More

Federal Judge Throws Out Hospital Groups’ 340B Lawsuit Against HHS

February 22, 2021
A federal judge has dismissed a lawsuit filed by hospital associations against HHS aimed at compelling it to take action against drugmakers who decline to offer 340B drug discounts to contract pharmacies. Read More
COVID-19

EU Unveils Vaccine Incubator to Combat COVID-19 Variants

February 19, 2021
The incubator will bring together researchers, biotech companies, manufacturers, regulators and public authorities to “monitor variants, exchange data and cooperate on adapting vaccines,” the commission said. Read More

Court Issues Emergency Stay of ITC’s 21-Month U.S. Ban on Botox Competitor

February 19, 2021
A U.S. appeals court judge this week issued an emergency stay of a December ruling by the U.S. International Trade Commission that the import, sale and marketing of a competitor to AbbVie ’s Botox wrinkle treatment, Jeuveau, must be stopped for nearly two years. Read More

States Seek to Tie Prescription Drug Prices to Canadian Reference Rates

February 19, 2021
Several U.S. states are pursuing their own versions of drug pricing policies introduced by the previous administration that would link the price of some prescription drugs to those in other “reference” countries. Read More

Report Shows 7.9 Percent of Drugs Ultimately Won Regulatory Approval Over Last Decade

February 18, 2021
The number of clinical trials that make it through to regulatory approval over the past decade is less than 8 percent, according to a new report on clinical success rates. Read More

EU Launches Vaccine Incubator to Take on Coronavirus Variants

February 18, 2021
The EU yesterday unveiled a plan to speed up regulatory approvals and manufacturing of vaccines against emerging strains of the SARS-CoV-2 virus that causes COVID-19. Read More

Woodcock Rebuffs Proposed ‘Firewall’ Between FDA Staff Following Aducanumab Dispute

February 18, 2021
Acting FDA Commissioner Janet Woodcock rejected a proposal to put up a “firewall” between FDA staff involved in pre-submission interactions and staff working on post-submission drug and biologic reviews and decisions, defending the agency’s collaboration with sponsors as critical to the development process. Read More
Previous 1 2 3 4 5 6 7 8 9 … 821 822 Next

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • WhiteHouse.gif

    President Biden Issues Executive Order on U.S. Supply Chain

  • roche.gif

    Priority Healthcare Settles Diabetes Test Lawsuit with Roche for $43 Million

  • Effective text

    Pfizer/BioNTech Vaccine Equally Effective for All Age Groups, Israeli Study Says

  • Siemens Healthineers logo

    Siemens Healthineers’ COVID-19 Antigen Lab Test Receives CE Mark

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing